These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 3284149
1. Medical castration using megestrol acetate and minidose estrogen. Johnson DE, Babaian RJ, Swanson DA, von Eschenbach AC, Wishnow KI, Tenney D. Urology; 1988 May; 31(5):371-4. PubMed ID: 3284149 [Abstract] [Full Text] [Related]
2. Megestrol acetate and minidose estrogen in prostatic carcinoma. Geller J. Urology; 1988 Sep; 32(3):281-3. PubMed ID: 3413920 [No Abstract] [Full Text] [Related]
4. Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate. Venner PM, Klotz PG, Klotz LH, Stewart DJ, Davis IR, Orovan WL, Ramsey EW. Semin Oncol; 1988 Apr; 15(2 Suppl 1):62-7. PubMed ID: 3285485 [Abstract] [Full Text] [Related]
5. Medical castration with megestrol acetate and minidose of diethylstilbestrol. Geller J, Albert J, Yen SS, Geller S, Loza D. Urology; 1981 Apr; 17(4 Suppl):27-33. PubMed ID: 6782738 [No Abstract] [Full Text] [Related]
8. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH). Geller J, Albert J. Urol Res; 1987 Apr; 15(3):151-3. PubMed ID: 3629749 [Abstract] [Full Text] [Related]
9. Megestrol acetate in the treatment of metastatic carcinoma of the prostate. Venner P. Oncology; 1992 Apr; 49 Suppl 2():22-7. PubMed ID: 1461622 [Abstract] [Full Text] [Related]
10. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol. Geller J, Albert J, Yen SS, Geller S, Loza D. J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942 [Abstract] [Full Text] [Related]
11. Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages. Prescrire Int; 2012 Dec; 21(133):292. PubMed ID: 23373095 [Abstract] [Full Text] [Related]
15. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer. Bonomi P, Pessis D, Bunting N, Block M, Anderson K, Wolter J, Rossof A, Slayton R, Harris J. Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650 [Abstract] [Full Text] [Related]
16. Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study. Lundgren R, Sundin T, Colleen S, Lindstedt E, Wadström L, Carlsson S, Hellsten S, Pompeius R, Holmquist B, Nilsson T. Scand J Urol Nephrol; 1986 Mar; 20(2):101-5. PubMed ID: 3529368 [Abstract] [Full Text] [Related]
17. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate. Rennie PS, Bruchovsky N, Goldenberg SL, Lawson D, Fletcher T, Foekens JA. J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378 [Abstract] [Full Text] [Related]
19. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07. Pilepich MV, Buzydlowski JW, John MJ, Rubin P, McGowan DG, Marcial VA. Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):175-80. PubMed ID: 7721614 [Abstract] [Full Text] [Related]